{"metadata": {"organization_names": [], "person_names_verified": [], "organization_names_verified": ["mdrna inc", "mdrna, inc.", "cequent pharmaceuticals, inc.", "calais acquisition corp."], "vars": {"Party": {"American Stock Transfer & Trust Company, LLC": "[[Party 2]]", "This Amendment No. 3 to Rights Agreement (this \u201cAmendment\u201d), which is effective [[Date 1: Date]], is by and between MDRNA, Inc. (f/k/a Nastech Pharmaceutical Company Inc.": "[[Party 1]]"}}, "entities_rejected": [], "person_names": [], "agreement_id": "1061cc4fa85bf29834d4eb579c0e6d8c7b0abd3ba3a4ca3f19d691c0b79190c6", "topics": [], "terms": ["**AMENDMENT NO. 3 TO RIGHTS AGREEMENT**", "**NOW, THEREFORE**", "**WHEREAS**", "*[remainder of page intentionally left blank; signature page follows]*", "\u201c**Merger Agreement**\u201d", "\u201cBoard\u201d", "\u201cCequent\u201d", "\u201cCompany\u201d", "\u201cForm of Right Certificate\u201d", "\u201cMerger Sub\u201d", "\u201cRights Agent\u201d", "\u201cSummary of Rights to Purchase Preferred Shares\u201d"]}}